How NINDS Supports Parkinson Disease Research

In part one of this series, Dr. Greg Cooper talks with Drs. Trey Bateman and Gregg Day about blood-based biomarkers, anti-amyloid therapies, and other highlights from the 2026 Alzheimer Association International Conference. Disclosures can be found at Neurology.org. 

Dr. Shuvro Roy talks with Prof. Catherine Jutzeler about how age influences neurologic and functional recovery after spinal cord injury and how these findings could inform treatment and future clinical trials. Read the related article in Neurology®. Disclosures can be found at Ne ...  Show more

Dr. Jason Crowell and Dr. Colin Hoy discuss the concept of prodromal Parkinson disease and the ethical considerations surrounding its diagnosis.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209522   

Send us Fan MailThis week, Rob and Zach will be talking about Parkinson's Disease (PD) DrugsWe will be discussing the following topics within this episode on Parkinson's Disease (PD) Drugs!Anatomy of Basal GangliaDirect vs. Indirect PathwayPathophysiology and Mechanism of Action ...  Show more

Dr. Vikram Karnik and Dr. Rob de Bie discuss early vs. delayed start of Levodopa in early Parkinson disease, and what it means for our clinical practice. Show reference: https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.29796   This podcast is sponsored by arg ...  Show more

Welcome back to NPTE Studycast, your indispensable guide for mastering the NPTE! In this episode, we're diving deep into Parkinson's Disease—a subject crucial not just for the NPTE but also for your real-world clinical practice. Listen in to expand your understanding and enhance ...  Show more